63 results
2021 ACR/VF Guidelines for Management of Giant Cell Arteritis (GCA)

#GiantCell #Arteritis #GCA #ACR2021 #Management #rheumatology #algorithm
Guidelines for Management ... Cell Arteritis (GCA ... GiantCell #Arteritis #GCA ... #ACR2021 #Management ... #rheumatology #
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management ... for Treatment & Management ... Cell Arteritis (GCA ... Sources: GCA ... Guidelines #algorithm #rheumatology
Giant Cell (Temporal) Arteritis

Dr. Ann Marie Kumfer @AnnKumfer

#GiantCell #Temporal #Arteritis #Diagnosis #Management #GCA #rheumatology
Arteritis #Diagnosis #Management ... #GCA #rheumatology
Hypereosinophilia and Hypereosinophilic Syndrome

 • Secondary Hypereosinophilic Syndrome
 • Clinically Relevant HES Variants
 • When to
Hypereosinophilic Syndrome ... Hypereosinophilic Syndrome ... suspect underlying hematologic ... #HES #Hematology ... eosinophils #diagnosis #management
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Cell Arteritis (GCA ... ) - Vasculitis Management ... GiantCell #Arteritis #GCA ... #Vasculitis #Management ... Guidelines #algorithm #rheumatology
Treatment of giant cell arteritis (GCA)

1st Line Strategy - GC 0.7 mg/kg/day, except for:
 • Aortitis
cell arteritis (GCA ... or SC for > 1 year ... weekly SC for > 1 year ... #Treatment #Management ... #Indications #rheumatology
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
ANCA Vasculitis Management ... , GC+CYC, GC+AZA ... , GC+MMF or GC alone ... ANCA #Vasculitis #Management ... Guidelines #algorithm #rheumatology
VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
Clinical Syndrome:
 • Common Clinical Features: alveolitis, ear and
Features: alveolitis, ear ... vasculitis • Hematologic ... criteria for 1) hematologic ... myeloid cells NEJM ... Autoinflammatory #Somatic #rheumatology
2021 ACR/VF Guidelines for Management of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

#Granulomatosis #Polyangiitis #GPA
Guidelines for Management ... Polyangiitis (GPA ... #Polyangiitis #GPA ... #MPA #ACR2021 #Management ... #rheumatology #
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
Antiphospholipid Syndrome ... Antiphospholipid #Syndrome ... #APS #management ... EULAR2019 #guidelines #rheumatology ... #hematology #treatment